Home » Merck Canada Sues to Block Mylan’s Generic Singulair
Merck Canada Sues to Block Mylan’s Generic Singulair
Merck Canada sued Mylan Pharmaceuticals in New Jersey federal court for allegedly infringing a Merck patent when it sought U.S. Food and Drug Administration approval for a generic version of the asthma treatment Singulair.
Law360
Law360
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May